my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
ATRIVA aims to develop new antiviral therapies against different respiratory viral infections. Founded in 2015, ATRIVA attracted seasoned experts in virology and drug development to form a unique venture targeting the fast and successful validation of a novel approach to fight infectious diseases In more
Bats don’t only carry the deadly Ebola virus, but are also a reservoir for a new type of influenza virus. These newly discovered flu viruses could potentially also attack the cells of humans and livestock, researchers at the University of Zurich have now shown. Seasonal outbreaks of the flu are caus more
Atriva Therapeutics, a biopharmaceutical company pioneering the development of host-targeting antiviral therapies, announced the first closing in its ongoing series A financing round lead by Meneldor and High-Tech Gründerfonds (HTGF). The Company founders and management joined the round, also. These more
Virus-like particles (VLPs) are protein-based structures that mimic viruses and bind to antibodies. Because VLPs are not infectious, they show considerable promise as vaccine platforms for many viral diseases, including influenza. Realizing that fine details about influenza VLPs were scant, a team o more
This short video explains how structural biology can be used to help fight influenza. The clip, which was developed by ELLS in collaboration with EMBL Grenoble scientists working on the EU-funded Flupharm project, is a great tool to introduce students to the topics of influenza, infectious disea ... more
Influenza virus infection represents a major threat to public health worldwide. There is no biologically relevant, reproducible, and readily available in vitro model for predicting the infectivity of influenza viruses in humans. Based on the long-term expanding 3D human airway organoids, we develope more
by Frédéric Debellut, Nathaniel Hendrix, Justin R. Ortiz, Philipp Lambach, Kathleen M. Neuzil, Niranjan Bhat, Clint Pecenka Immunization of pregnant women against seasonal influenza remains limited in low- and lower-middle-income countries despite being recommended by the World Health Organizatio more
Viruses, Vol. 10, Pages 339: Kinetic, Thermodynamic, and Structural Analysis of Drug Resistance Mutations in Neuraminidase from the 2009 Pandemic Influenza Virus Viruses doi: 10.3390/v10070339 Authors: Jana Pokorná Petr Pachl Elena Karlukova Jakub Hejdánek Pavlína Řezáčová Aleš Ma more
BIOQUAL, Inc. (Bioqual) is a public traded, research, development and consulting company and is engaged in providing quality research, development and consulting services to Government and commercial contract clients. The company is accredited by the association for the assessment and accreditation more
iBio, Inc. (iBio, formerly iBioPharma, Inc.) is a biotechnology company, engaged in the development of vaccines and therapeutic proteins based on its plant-based iBioLaunch platform technology, which is used in the manufacture of biopharmaceuticals. Its products include influenza vaccines, biodefenc more
Introduction Global Markets Direct’s, 'Influenza - Pipeline Review, H1 2012', provides an overview of the Influenza therapeutic pipeline. This report provides information on the therapeutic development for Influenza, complete with latest updates, and special features on late-stage and discontinued more
Watchlist
This is where you can add this topic to your personal favourites
© 1997-2019 LUMITOS AG, All rights reserved
